STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 61 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $125,000 | -92.9% | 11,802 | -93.6% | 0.00% | -100.0% |
| Q4 2018 | $1,761,000 | -38.0% | 185,395 | +8.3% | 0.00% | 0.0% |
| Q3 2018 | $2,841,000 | -0.4% | 171,120 | -3.7% | 0.00% | 0.0% |
| Q2 2018 | $2,853,000 | -14.1% | 177,731 | -18.1% | 0.00% | 0.0% |
| Q1 2018 | $3,322,000 | -1.9% | 217,129 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $3,387,000 | +39.2% | 217,129 | -1.0% | 0.00% | 0.0% |
| Q3 2017 | $2,434,000 | +119.7% | 219,252 | +82.0% | 0.00% | 0.0% |
| Q2 2017 | $1,108,000 | +88.1% | 120,477 | +74.9% | 0.00% | – |
| Q1 2017 | $589,000 | -30.9% | 68,899 | -13.6% | 0.00% | – |
| Q4 2016 | $853,000 | -3.7% | 79,719 | -2.6% | 0.00% | – |
| Q3 2016 | $886,000 | +281.9% | 81,819 | +138.3% | 0.00% | – |
| Q2 2016 | $232,000 | +241.2% | 34,337 | +133.9% | 0.00% | – |
| Q1 2016 | $68,000 | – | 14,679 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|